September's top stories: GSK-Theravance COPD study, AstraZeneca cUTI results

GlaxoSmithKline (GSK) and Theravance reported the initial results of SUMMIT COPD survival study, AstraZeneca announced positive Phase III results of CAZ-AVI in patients with cUTI, and Boehringer and Lilly's diabetes drug Jardiance showed reduction in…
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news